Viewing Study NCT02601703


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-02-24 @ 5:04 PM
Study NCT ID: NCT02601703
Status: COMPLETED
Last Update Posted: 2019-07-31
First Post: 2015-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Sponsor: Glenmark Pharmaceuticals Ltd. India
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-08
Start Date Type: None
Primary Completion Date: 2016-10
Primary Completion Date Type: ACTUAL
Completion Date: 2016-10
Completion Date Type: ACTUAL
First Submit Date: 2015-11-09
First Submit QC Date: None
Study First Post Date: 2015-11-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-30
Last Update Post Date: 2019-07-31
Last Update Post Date Type: ACTUAL